Adam Cutler was Chief Financial Officer and Chief Business Officer of Azora Therapeutics. He brings more than 25 years of biotechnology industry experience across corporate finance, business development, investor relations, equity research, and strategic planning. Prior to Azora, he served as CFO of Mural Oncology, Q32 Bio, and Molecular Templates, where he led significant financing, business development, and investor relations activities. Earlier in his career, Mr. Cutler was a senior biotechnology equity research analyst at Credit Suisse, Canaccord Genuity, JMP Securities, and Bank of America. He holds a B.A. in Economics from Brandeis University.